All Pharma News
Report from Extraordinary General Meeting in LIDDS

Report from Extraordinary General Meeting in LIDDS
GLOBENEWSWIRE
11 Mar 2022
Share Share
LIDDS publishes agenda for the company`s Capital Markets Day 2022

LIDDS publishes agenda for the company`s Capital Markets Day 2022
GLOBENEWSWIRE
04 Mar 2022
Share Share
Statement from LIDDS regarding convertible note agreement

Statement from LIDDS regarding convertible note agreement
GLOBENEWSWIRE
24 Feb 2022
Share Share
LIDDS AB (publ) Year-end report 2021

LIDDS AB (publ) Year-end report 2021
GLOBENEWSWIRE
23 Feb 2022
Share Share
LIDDS secures financing of 40.8 MSEK to create foundation for new partnerships

LIDDS secures financing of 40.8 MSEK to create foundation for new partnerships
GLOBENEWSWIRE
22 Feb 2022
Share Share
LIDDS Next Step with NanoZolid formulated docetaxel

LIDDS Next Step with NanoZolid formulated docetaxel
GLOBENEWSWIRE
21 Feb 2022
Share Share
LIDDS announces positive topline results from the phase I study of NanoZolid

LIDDS announces positive topline results from the phase I study of NanoZolid
GLOBENEWSWIRE
29 Dec 2021
Share Share
LIDDS Announces Appointment of Matthew Lindon as Chief Scientific Officer

LIDDS Announces Appointment of Matthew Lindon as Chief Scientific Officer
GLOBENEWSWIRE
20 Dec 2021
Share Share
LIDDS patent covering the NanoZolid® production process granted

LIDDS patent covering the NanoZolid® production process granted
GLOBENEWSWIRE
28 Sep 2021
Share Share
LIDDS Interim report January – June 2021

LIDDS Interim report January – June 2021
GLOBENEWSWIRE
26 Aug 2021
Share Share